We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Invalidates Key Norvasc Patent
Appeals Court Invalidates Key Norvasc Patent
April 3, 2007
A federal appeals court has invalidated a key patent held by Pfizer for its blockbuster high blood pressure treatment Norvasc,
the company said March 22.